Azitra, Inc. (AZTR) vs Senti Biosciences, Inc. (SNTI)
Azitra, Inc. and Senti Biosciences, Inc. are both Biotechnology companies. Azitra, Inc. and Senti Biosciences, Inc. are of similar size ($10.1M and $10.0M). Senti Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 2.5×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against −70.7%. Azitra, Inc. has the higher net margin (0.00% vs −3,789.3%) and the lower return on invested capital (−1,272.5% vs 0.00%). Across the 14 metrics below, Azitra, Inc. leads on 12 and Senti Biosciences, Inc. on 2.
Valuation
Profitability
| Metric | AZTR | SNTI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (4,181.12%) | 0.00% |
| Net margin | 0.00% | (3,789.30%) | 0.00% |
| Free cash flow margin | 0.00% | (2,900.38%) | 0.00% |
| Return on equity | (256.67%) | (466.46%) | (57.72%) |
| Return on assets | (190.69%) | (97.52%) | (49.22%) |
| Return on invested capital | (1,272.49%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack